Answers are grounded in this paper and cite their sources.
The study reveals that miR-21 outperforms NT-proBNP for diagnosing pulmonary hypertension in COPD.
miR-21 may serve as a useful and reliable biomarker for diagnosing PH in COPD patients, outperforming the traditional biomarker NT-proBNP.
No takes yet. Share an insight, caveat, or question.
Eid et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: